Serotonin transporter inhibition prevents and reverses monocrotaline-induced pulmonary hypertension in rats.. Serotonin transporter inhibition prevents and reverses monocrotaline-induced pulmonary hypertension in rats.: 5-HT Transporter Inhibition Prevents PH

Archive ouverte

Guignabert, Christophe | Raffestin, Bernadette | Benferhat, Rima | Raoul, William | Zadigue, Patricia | Rideau, Dominique | Hamon, Michel | Adnot, Serge | Eddahibi, Saadia

Edité par CCSD ; American Heart Association -

9 pages. International audience. BACKGROUND: Progression of pulmonary hypertension (PH) is associated with increased lung expression of the serotonin transporter (5-HTT), which leads to hyperplasia of the pulmonary artery smooth muscle cells (PA-SMCs). Given the postulated causal relation between 5-HTT overexpression and PH, we herein investigated whether the highly selective 5-HTT inhibitor fluoxetine prevented and/or reversed PH induced by monocrotaline (MCT) in rats. Selective 5-HT(1B/1D), 5-HT(2A), and 5-HT(2B) receptor antagonists were used for comparative testing. METHODS AND RESULTS: MCT injection (60 mg/kg SC) was followed by an early peak in lung 5-HTT expression on day 1, which preceded the onset of PH. Established PH on day 15 was associated with a sustained 5-HTT increase. Continued fluoxetine treatment completely prevented PA-SMC proliferation and PH development and also suppressed the late 5-HTT increase, without affecting the early peak. The 5-HT receptor antagonists did not affect PH. Fluoxetine (10 mg . kg(-1) . d(-1) PO) started 3 weeks after MCT injection completely reversed established PH, normalizing PA pressure and structure. MCT-induced PH was also associated with increased expression of various cytokines, but only interleukin-1beta and monocyte chemotactic protein-1 increased at the early phase and stimulated 5-HTT expression by cultured PA-SMCs. CONCLUSIONS: Upregulation of lung 5-HTT induced by MCT appears necessary to initiate the development of pulmonary vascular remodeling, whereas a sustained increase in 5-HTT expression may underlie both the progression and the maintenance of MCT-induced PH. Complete reversal of established PH by fluoxetine provides a rationale for new therapeutic strategies in human PH.

Suggestions

Du même auteur

Endothelial-derived FGF2 contributes to the progression of pulmonary hypertension in humans and rodents.. Endothelial-derived FGF2 contributes to the progression of pulmonary hypertension in humans and rodents.: FGF2 Inhibition in Pulmonary Hypertension

Archive ouverte | Izikki, Mohamed | CCSD

12 pages. International audience. Pulmonary hypertension (PH) is a progressive, lethal lung disease characterized by pulmonary artery SMC (PA-SMC) hyperplasia leading to right-sided heart failure. Molecular events o...

Transgenic mice overexpressing the 5-hydroxytryptamine transporter gene in smooth muscle develop pulmonary hypertension.. Transgenic mice overexpressing the 5-hydroxytryptamine transporter gene in smooth muscle develop pulmonary hypertension.: Pulmonary Hypertension in Transgenic 5-HTT+ Mice

Archive ouverte | Guignabert, Christophe | CCSD

9 pages. International audience. One intrinsic abnormality of pulmonary artery smooth muscle cells (PA-SMCs) in human idiopathic pulmonary hypertension (iPH) is an exaggerated proliferative response to internalized ...

Lung Overexpression of Angiostatin Aggravates Pulmonary Hypertension in Chronically Hypoxic Mice

Archive ouverte | Pascaud, Marie-Aude | CCSD

International audience. Exposure to hypoxia leads to the development of pulmonary hypertension (PH) as a consequence of pulmonary smooth mus-cle hyperplasia. Hypoxia concomitantly stimulates lung expres-sion of angi...

Chargement des enrichissements...